Detection of viable organisms in leprosy patients treated with multidrug therapy

Acta Leprologica

Volumn 11, Issue 3, 1999, Pages 89-92

  Gupta, U D ^a   Katoch, K ^a   Singh, H B ^a   Natrajan, M ^a   Sharma, V D ^a   Katoch, V M ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Bioluminescence; Leprosy; Mouse foot pad inoculation; Mycobacterium leprae; Persisters; Viability

Indexed keywords

ADENOSINE TRIPHOSPHATE; CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ADULT; ARTICLE; BIOLUMINESCENCE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FOOT PAD; HUMAN; LEPROSY; MYCOBACTERIUM LEPRAE; SKIN BIOPSY;

ADULT; ANIMALS; BIOLOGICAL ASSAY; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY; LUMINESCENT MEASUREMENTS; MICE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; TIME FACTORS;

EID: 0032752556     PISSN: 00015938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. D'ARCY HART (P.), REES (R.J.W.). Effect of macrocyclon in acute and chronic pulmonary tuberculosis infection in mice as shown by viable and total bacterial count. J. Exp. Pathol., 1960, 41: 414-420.
2. DESIKAN (K.V.), VENKATARAMANAIAH (H.N.). A modified method of harvesting M.leprae from foot pads of mice. Lepr. India, 1976, 48:157-162.
3. GUPTA (U.D.), KATOCH (K.), NATRAJAN (M.), SHARMA (V.D.), SHARMA (R.K.), SHIVANNAVAR (C.T.) KATOCH (V.M.). Viability determination of M.leprae: Comparison of normal mouse foot pad and bacillary ATP bioluminescence assay. Acta Leprol., 1997, 10: 209-212.
4. KATOCH (K.), RAMU (G.), RAMANATHAN (U.), SENGUPTA (U.), SREEVATSA, SHARMA (V.D.), SHIVANNAVAR (C.T.), KATOCH (V.M.). Results of a modified WHO regimen in highly bacilliferous BL/LL patients. Int. J. Lepr., 1989, 57: 451-457.
5. KATOCH (K.), NATRAJAN (M.), BAGGA (A.), KATOCH (V.M.). Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT. Int. J. Lepr., 1991, 59: 248-254.
6. KATOCH (V.M.), KATOCH (K), SHIVANNAVAR (C.T.), SHARMA (V.D.), PATIL (M.A.), BHARADWAI (V.P.). Effect of chemotherapy on viability of M.leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Int. J. Lepr., 1989, 57: 615-621.
7. MARCHOUX CHEMOTHERAPY STUDY GROUP. Relapses after long term follow up of multibacillary patients treated by WHO-multidrug regimen. Int. J. Lepr., 1995, 63: 195-201.
8. MCRAE (D.H.), SHEPARD (C.C.). Relationship between staining quality of Mycobacterium leprae and infectivity of mice. Infect. Immun. 1971, 3: 116-120.
9. RAMU (G.), DESIKAN (K.V.). A study of scrotal biopsy in subclinical cases of lepromatous leprosy. Lepr. India, 1979, 51: 341.
10. RIDLEY (D.S.). Bacterial indices. In: Leprosy in theory and practice. Cochrane, R.G. and Davey T.F. eds. Briston: John Wright and Sons Ltd., 1964, pp. 620-622.
11. SHETTY (V.P.), SUCHITRA (K), UPLEKAR (M.W.), ANTIA (N.H.). Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug treated leprosy patients. Lepr. Rev., 1992, 63: 329-336.
12. SREEVATSA, GIRDHAR (B.K.), DESIKAN (K.V.). Screening of drug resistant strains of M.leprae in lepromatous leprosy patients under multidrug treatment. Indian J. Med. Res., 1988, 87: 139-143.
13. Subcommittee on clinical trials of the chemotherapy of leprosy (THELEP) scientific working group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Persisting Mycobacterium leprae among THELEP trials patients in Bamako and Chingleput. Lepr. Rev., 1987, 58: 325-327.